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Abstract
Purpose
Daily online adaptive plan quality in magnetic resonance imaging guided radiation therapy
(MRgRT) is di cult to assess in relation to the fully optimized, high quality plans traditionally
established o ine. Machine learning prediction models developed in this work are capable
of predicting 3D dose distributions, enabling the evaluation of online adaptive plan quality
to better inform adaptive decision‐making in MRgRT.

Methods
Arti cial neural networks predicted 3D dose distributions from input variables related to
patient anatomy, geometry, and target/organ‐at‐risk relationships in over 300 treatment
PDF
plans from 53 patients receiving adaptive, linac‐based MRgRT for abdominal cancers. The
Help
models do not include any beam related variables such as beam angles or uence and were
optimized to balance errors related to raw dose and speci c plan quality metrics used to
guide daily online adaptive decisions.

Results
Averaged over all plans, the dose prediction error and the absolute error were 0.1 ± 3.4 Gy
(0.1 ± 6.2%) and 3.5 ± 2.4 Gy (6.4 ± 4.3%) respectively. Plan metric prediction errors were
−0.1 ± 1.5%, −0.5 ± 2.1%, −0.9 ± 2.2 Gy, and 0.1 ± 2.7 Gy for V95, V100, D95, and Dmean
respectively. Plan metric prediction absolute errors were 1.1 ± 1.1%, 1.5 ± 1.5%, 1.9 ± 1.4 Gy,
and 2.2 ± 1.6 Gy. Approximately 10% (25) of the plans studied were clearly identi ed by the
prediction models as inferior quality plans needing further optimization and re nement.
https://aapm.onlinelibrary.wiley.com/doi/full/10.1002/acm2.12884
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Conclusion
Machine learning prediction models for treatment plan 3D dose distributions in online
adaptive MRgRT were developed and tested. Clinical integration of the models requires
minimal e ort, producing 3D dose predictions for a new patient’s plan using only target and
OAR structures as inputs. These models can enable improved work ows for MRgRT through
more informed plan optimization and plan quality assessment in real time.

1 INTRODUCTION
The e cacy of radiation therapy (RT) for abdominal cancers is limited by a prescription dose
(Rx) that can be tolerated without toxicity in nearby organs‐at‐risk (OARs). The abdominal OARs
(liver, kidney, and all GI organs, etc.) are highly deformable in nature and their daily motion
throughout treatment is substantial. Interfraction motion over 3 cm is possible.1-3 GI OARs
(stomach, duodenum, esophagus, small and large intestines) are also sensitive to high doses of
radiation.4, 5 As a result, tumors associated with such di cult abdominal sites have not been
treated to the same curative doses that have been achieved for other sites, ie a biologically
e ective dose (BED) >100 Gy.6-8 Daily, online adaptive treatment with magnetic resonance
image guided RT (MRgRT) can provide an opportunity to simultaneously escalate gross tumor
volume (GTV) dose while meeting OAR constraints in these di cult cases.9 Both modeling
studies3, 10, 11 and completed phase I clinical trials12-14 have shown the feasability of ablative
dose escalation without signi cant adjacent organ toxicity in the central thorax and abdomen.
Such trials have shown an increase in both local control and overall survival while decreasing
radiation‐induced toxicity events, leading to a prospective clinical trial for further evaluation in
pancreatic cancer (SMART: NCT03621644).
As the use of online adaptive MRgRT has grown recently across a variety of clinics, both the
potential bene ts and practical di culties of its utilization are beginning to be understood.12PDF
21 But ample opportunity remains for assessment and improvement of online adaptive RT as
Help
this unique treatment method continues to develop clinically. Analysis of a collection of patient
data and their treatment plans in order to better understand and improve a particular RT
process can proceed in a variety of ways. But the most common method used recently falls
under the general term of knowledge‐based (KB) prediction models.22 KB methods have been
used to predict achievable dose‐volume histograms (DVHs),23, 24 plan metrics,25 and full 3D
dose distributions.26-31 In fact, using information from previously treated patients and plans
to better inform future procedures is now present in nearly all aspects of RT.32-35 Much of the
recent work related to KB methods for improving RT has focused on 3D dose prediction: voxel‐
by‐voxel prediction of dose for a “future” patient based on a collection of previously treated
patients’ plans and/or other relevant data. Such a focus is understandable because the ability
to accurately and robustly predict 3D dose volumes for future patients is signi cant. It produces
https://aapm.onlinelibrary.wiley.com/doi/full/10.1002/acm2.12884
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in a single model the ability to predict a wide variety of clinically relevant data such as target
and OAR dose‐volume metrics as well as conformity/homogeneity indices which may also be
important. Furthermore, 3D dose predictions could serve as novel inputs for treatment plan
optimization that may completely alter the paradigm under which RT planning currently
occurs.26, 28, 30
Despite the growth in applications of KB methods to solving interesting RT problems, a majority
of the most relevant work has focused on treatment sites such as prostate,23, 24, 26, 28, 31
head and neck,25, 29, 30 breast,28 and lung.36 There are limited studies dedicated to
abdominal cancers15, 27 because they are notoriously di cult to treat and there is minimal
consensus regarding the best RT treatment approaches.37 These sites are however expected to
bene t most directly from MRgRT and online plan adaptation. Application of KB methods to
online adaptive RT is also new, with very few previous studies.15 KB methods typically require
su cient data collection from previously treated patients and plans, and online adaptive RT is a
mostly new technique.
In this work, we have developed arti cial neural network (ANN) models to predict 3D dose
distributions within the GTV for MRgRT of abdominal cancers. The clinical goals are to enable
real‐time guidance for achievable plan quality of each online adaptive case, identify inferior
plans, and assure plan quality. Unlike some previous KB works,26, 27 our ANN models do not
require beam related variables such as beam angles and uence. They therefore can predict a
3D dose distribution for a new patient’s plan using only target and OAR structures as inputs. In
addition, the ANN models are simple in design and rely on small datasets. They do not require
signi cant training time and are not computationally demanding (no GPU required). As a result,
they can be integrated clinically with minimal e ort. To our knowledge, this work presents the
development and results of the rst 3D dose prediction models for online adaptive MRgRT.

2 MATERIALS AND METHODS
2.A Patient Characteristics

PDF
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As shown in Table 1, datasets from a total of 53 patients with abdominal cancers treated at
Washington University in St. Louis with online adaptive, linac‐based MRgRT were utilized. The
patient data were combined from two main treatment site groups, pancreas (n = 34) and
nonpancreas (n = 19). All patients were treated with one of two high BED protocols: stereotactic
body RT (SBRT, n = 48), having prescriptions of 50 Gy in 5 fractions (BED ~ 100 Gy) and critical
OAR (OARCRIT) dose constraints of less than 0.5 cubic centimeters (cc) receiving 36 Gy or more
(V36 < 0.5 cc); or hypofractionation (HYP, n = 5) having prescriptions of 67.5 Gy in 15 fractions
(BED ~ 100 Gy) and OARCRIT dose constraints of V50 < 0.5 cc. Overall, 260 out of 315 (82.5%)
treatment fractions were adapted.

https://aapm.onlinelibrary.wiley.com/doi/full/10.1002/acm2.12884
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Table 1. Statistics for the plans and GTV V95% and D95% values.
Patient Group

Type of Plan

# of Plans
SBRT

Pancreas

NonPancreas

All Patients

a

a

HYP

Total

V95%

D95%

Mean ± σ

Mean ± σ

29

4

33

86.2 ± 8.7

80.7 ± 12.6

Adapted

133

56

189

86.2 ± 8.8

78.5 ± 15.4

Simulation

16

1

17

94.6 ± 11.0

98.9 ± 13.0

Adapted

56

15

71

92.5 ± 10.3

94.1 ± 14.5

Simulation

45

5

50

89.3 ± 10.4

87.5 ± 15.5

Adapted

189

71

260

87.9 ± 9.6

82.7 ± 16.6

Simulation

Simulation plans are created on the patient's simulation image, receive normal planning time, attention, optimization,

and checks just like traditional IMRT plans, and serve as the starting point of plan adaptation for the rst fraction. V95% is
the percentage of the GTV volume receiving 95% or more of Rx. D95% is the minimum dose received by 95% of the GTV,
given as a percentage of Rx.

2.B Treatment Plan Adaptation Techniques
Detailed descriptions of the speci c work ows and planning strategies for adaptive MRgRT
using the ViewRay linac system (Viewray, Cleveland, OH) have been presented previously.12, 13,
21, 38-41 A brief summary, with particular focus on the details related to the online adaptive
process, follows.
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Table 2 includes key de nitions for structures associated with the planning process. Additional
OARs beyond those in OARCRIT may have been included in the plan optimization such as the
spinal cord, liver, aorta, and one or both kidneys. PTVOPT is used as the target in the plan
optimization instead of the PTV. It is often observed in these plans that, after subtracting
OAR5 mm, not all of the GTV will be inside PTVOPT. The planning strategy is quite di erent from
traditional IMRT. PTV V95>=95% was still one planning goal, but the hard OARCRIT dose
constraints caused this target coverage goal to be rarely achievable. Hotspots were generally
limited to <150% of the Rx inside the GTV.
Table 2. Structure names and de nitions used throughout this work.

https://aapm.onlinelibrary.wiley.com/doi/full/10.1002/acm2.12884
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Planning

De nition

Structure
GTV

Gross tumor volume

PTV

GTV + 5 mm isotropic expansion

OARCRIT

All abdomen organs in close proximity of GTV (esophagus, stomach, duodenum, large bowel,
small bowel)

OAR5mm

OARCRIT + 5 mm isotropic expansion

PTVOPT

PTV minus OAR5 mm:
used as target in plan optimization

The adaptive process work ow is shown visually in Fig. 1. To start the adaptive work ow, on
each treatment day the most recently used treatment plan is loaded and a new volumetric MRI
with exhale‐breath‐hold is scanned after patient setup. The couch table is shifted according to
manual registration of the visible GTV in the new image with the GTV in the loaded plan.
Following this registration, all other contours in the loaded plan are then rigidly copied onto the
new images. All OARs within 30 mm of the PTV are re‐contoured on the new MR image by the
attending physician. The overwhelming majority (>90%) of plans in this study had no GTV
contour change. If the GTV is recontoured, most commonly at a patient’s rst adapted
treatment fraction, the PTV is regenerated by expanding the GTV by an isotropic 5 mm margin.
The attending medical physicist reviews the manual OAR segmentation and assesses for other
organ changes such as known areas of heterogeneity and skin surface position. Note that other
institutions may choose to use the original simulation plan as the starting point for all onlinePDF
adaptive plans.15 The use of the most recently treated plan for this purpose is simply the
chosen work ow at our institution.

https://aapm.onlinelibrary.wiley.com/doi/full/10.1002/acm2.12884
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Fig. 1
Open in gure viewer

PowerPoint

Work ow showing the steps and estimated timeline to the online adaptive MRgRT process.

The new radiation dose distribution is then calculated by applying the loaded plan to the
current day’s anatomy. Target coverage and OAR doses are reassessed relative to plan goals
and constraints. Only if target coverage can clearly be improved or any critical OAR dose
constraint is not met will a new plan be created. The new plan is developed by reoptimization
using the same beam angles and objective functions established in the currently loaded plan. In
rare cases (~4%), attempts are made to adjust optimization objectives to further reoptimize the
plan. After the plan is reoptimized, the attending physician evaluates and approves the plan.
Physics quality assurance steps are taken next,42 and then the plan is delivered at free
breathing, with real‐time, continuous 2D cine MR guidance for gating at the planned end‐of‐
exhalation phase.41

PDF

All plans discussed in this work were developed with OAR isotoxicity prioritized over target

Help

coverage . Essentially, the OARCRIT constraints discussed above were hard constraints that must
not be exceeded, regardless of target coverage. Therefore the goal of the model predictions in
this work is identifying improvements to GTV coverage while maintaining the same OAR
avoidance. By contrast, most previous KB prediction models aimed at identifying planning
improvements related to OAR dose sparing while maintaining uniform target coverage, eg PTV
V95% > 95%.23, 24, 26, 27, 31

2.C GTV 3D Dose Distribution Prediction ANN Model

https://aapm.onlinelibrary.wiley.com/doi/full/10.1002/acm2.12884
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In previously published KB methods, parameters associated with target size/shape, distance
relationships between the target and OARs, and patient size were deemed important for
predicting OAR 3D dose, with the most critical parameter the minimum distance from a voxel
inside an OAR to the target surface.23, 26, 27 We have a similar approach in this study to
predict 3D dose distributions inside the GTV. Our model input parameters include the
minimum distances from a voxel inside the GTV to surfaces of various OAR structures (OARCRIT,
OAR5mm, etc.). To improve the prediction model accuracy and robustness, additional
parameters derived from the distance and geometrical relationships between OARs and the
GTV were added and are explained in Table 3. GTV V95 and D95 were found to strongly
correlate with these additional parameters. It is important to note that we did not include any
beam parameters (beam angles or uence) so that the developed models could predict 3D
dose before a treatment beam plan is devised. This is di erent from some previous work using
ANN models to make 3D dose predictions.26, 27
Table 3. List of 16 ANN model input variables.
#

ANN Input Variables

#

ANN Input Variables

1

% of all voxels within 5 mm occupied by OAR5 mm

9

Square root of min distance to GTV surface

2

% of all voxels within 10 mm occupied by OAR5 mm

10

Min distance to OAR5 mm
(>=0 only)

3

% of all voxels within 15 mm occupied by OAR5 mm

11

b

Min distance to OAR5mm
(<=0 only)

4

% of all voxels within 20 mm occupied by OAR5 mm

5

% of GTV occupied by OAR5 mm

a

12

Square root of min distance to OAR5mm

13

Min distance to PTVOPT

PDF
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(>=0 only)

6

Distance to GTV centroid

14

Min distance to PTVOPT
(<=0 only)

https://aapm.onlinelibrary.wiley.com/doi/full/10.1002/acm2.12884
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ANN
Input Variables
Max distance
from GTV centroid to GTV surface

a

#15

ANN
Input Variables
Min distance
to (OAR5 mm‐OARCRIT)

Each variable was calculated for all voxels inside the GTV for each plan unless indicated otherwise. Some ANN model input
variables could have both positive and negative values, with negative values corresponding to an overlap between the GTV
and the OAR structure associated with the variable.
a

Every voxel for the GTV had the same value.

b

A linear correlation was observed between this distance metric and dose but only up to a distance of ~ 16 mm. So this

metric has a maximum value of 16 mm for any voxel.

In a separate study, we determined that for linac‐based MRgRT plans, plan quality comparisons
between online adapted plans and fully optimized o ine simulation plans showed no
statistically signi cant di erences. Therefore, we developed our models using both o ine
(simulation) and adapted plans. The model prediction output was per voxel dose value
normalized to Rx. By tracking the model prediction accuracy in preliminary experiments, we
identi ed the most relevant input variables, eliminated the less signi cant ones, and simpli ed
the ANN models while avoiding over tting. Our nal ANN model was a two‐layer feed forward
neural network design (one hidden layer: 2 nodes, one output layer: 1 node), shown in Fig. 2. It
was implemented using MATLAB’s neural network toolbox. The default Levenberg‐Marquardt
backpropagation was used for model training. Other models with more nodes in the hidden
layer (eg up to ~ 5) provided very similar results if they were similarly optimized. Continuing to
increase the number of nodes further led to model over tting and clearly reduced model
performance. Adding more hidden layers was similar. As a result, we chose to keep the
simplest model possible that provided equal performance which was a model with two nodes
in a single hidden layer. A wide range of di erent loss functions were also tested, including
some that weighted di erent types of voxels di erently.26 But the loss function that provided
the most consistent prediction accuracy among the many that were tested was mean square
PDF
error.
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Fig. 2
Open in gure viewer

PowerPoint

The ANN models used in this work, with three distinct layers: (1) input layer with 17 (16 inputs + 1
bias) nodes, (2) hidden layer with two activation nodes and one bias node, and (3) output layer
with one activation node. The arrows represent the connections between nodes in each layer
and are mathematically associated with the weighting parameters that get updated and

PDF
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optimized during model training.

A owchart for ANN model training, testing, and development is shown in Fig. 3. The simple
ANN model design we eventually adopted allowed for very fast model training. So it was
straightforward to utilize cross validation to train and validate the ANN models. We were not
limited to training potential models and then testing on a small group of separate test
patients/plans only once. The total 310 plans (50 simulation, 260 adapted) were separated into
training and testing groups as follows: the 53 patients were split into ten groups of ve and one
group of three, then each group was cycled through as the test group. For each iteration of the
cross validation, all of the plans from the test group patients made up the testing data while all
https://aapm.onlinelibrary.wiley.com/doi/full/10.1002/acm2.12884
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the plans from the other ten groups served as training data. The cross validation was done on a
patient‐by‐patient basis instead of a plan‐by‐plan basis to avoid testing the models on any plan
coming from a patient whose plans were already used for model training.

Fig. 3
Open in gure viewer

PowerPoint

Process owchart for ANN model training and testing

PDF
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The ANN model datasets in each cross validation iteration were quite large, with the typical
training group composed of ~250 plans from 48 patients. The total number of voxels available
in such a training group dataset was >2 million. It was not necessary to use all available voxels
in any given cross validation to produce optimized and consistent model performance. So GTV
voxels for each plan from the training group were randomly sampled at a 1/20 ratio and then
accumulated to make the training dataset. This data sampling was chosen in an e ort to fairly
sample each set of GTV voxels regardless of GTV size di erences in the group while achieving
reduced model training time and consistent prediction results. Each cross validation iteration
utilized ~120,000 voxels after data sampling.
https://aapm.onlinelibrary.wiley.com/doi/full/10.1002/acm2.12884
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Once the training dataset from randomly sampled GTV voxels was created, it was further
separated into “training” and “validation” subsets at 85% and 15% respectively. The model was
trained with the “training” dataset until six consecutive error increases were observed on the
“validation” dataset or a maximum of 200 epochs was reached. Many di erent epoch cut‐o s
were also tested, but the results did not strongly depend on this variable. The nal training
method was chosen based on allowing the model to either naturally nd its optimal number of
epochs based on error increases in the “validation” dataset, or run through a su cient number
of epochs to reach model convergence.
In an e ort to ensure consistent model prediction performance, the model training sequence
was repeated 50 times and the predicted dose results on each plan in the test group were
averaged. The mean, mean absolute, and standard deviation errors of each entire 3D dose
distribution in the test group were calculated, as well as mean dose (Dmean), V95, V100, and
D95. DVHs for each real and predicted dose distribution and their di erences were determined
(% GTV volume error as a function of dose). This process was repeated for each iteration of the
cross validation until all patients were part of the test group, and then the overall results from
the cross validation were accumulated.

2.D Outlier Detection, Rejection, and Model Re nement
One main application of the prediction models is to identify inferior plans by comparing the
predicted plan quality metrics to those computed in the actual plans. This concept also allows
model re nement by excluding inferior plans from training.25, 26 To do so, inferior plans were
identi ed as any with an observed plan metric (V95, V100, or D95) outside the 95% prediction
interval (PI) of the original ANN model, with:
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The inferior plans outside the 95% PI were then discarded and the model was retrained. After
two rounds, a total of 25 inferior plans were identi ed and discarded. The model errors and
results are included only for the re ned model with 285 plans.

3 RESULTS
The prediction dose error statistics from the cross validation analysis are shown in Table 4.
Dose prediction error was computed as ΔDose = Dactual – Dpredicted , then averaged across all
plans of all patients. Many di erent combinations of input variables could produce similar
prediction dose errors yet distinct plan metric prediction errors. So it was important to track

https://aapm.onlinelibrary.wiley.com/doi/full/10.1002/acm2.12884
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plan metric prediction errors during model optimization as well. In the end the most optimized
ANN model was chosen based on the best balance between dose and plan metric error. As
shown in Table 5, overall plan metric prediction errors for V95, V100, D95, and Dmean were
generally low with mean absolute errors of 1.1%, 1.5%, 1.9 Gy, and 2.2 Gy respectively.
Removing inferior plans to make the re ned model helped to enhance its predictive ability for
dose values relevant to plan quality, despite only marginal improvements in overall dose
prediction errors.
Table 4. ANN model 3D dose prediction results.
Dose Prediction Error

Absolute Dose

Mean ± σ (% Rx)

Prediction Error
Mean ± σ (% Rx)

0.1 ± 3.4 Gy (0.1 ± 6.2%)

3.5 ± 2.4 Gy (6.4 ± 4.3%)

The listed errors represent the averages on a plan‐by‐plan basis.

Table 5. ANN model plan metric prediction results.
Metric

Prediction Error

Absolute Prediction

95%

R2

Error
PDF
V95 (%)

−0.1 ± 1.5

1.1 ± 1.1

3.3

0.97

V100 (%)

−0.5 ± 2.1

1.5 ± 1.5

5.0

0.95

D95 (Gy)

−0.9 ± 2.2

1.9 ± 1.4

4.6

0.95

Dmean

0.1 ± 2.7

2.2 ± 1.6

5.1

0.91

Help

(Gy)
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Averages across all plans for both raw and absolute prediction errors are given. 95%: the value required to encompass the
absolute error from 95% of all plans in the model. R2: coe cient of determination values for the linear t of actual vs
predicted plan metric values.

The dose prediction errors observed here are similar to previous e orts at 3D dose predictions
using ANN models,26, 27 where errors ranged from 2‐10% of Rx generally but had some
contributions up to 20% and greater. Care must be taken to recall that the fair comparison to
previous results with this work would be in relating published OAR dose errors to GTV dose
errors here. Previously published models focusing on OAR dose distributions also made
predictions for GTV/PTV dose,26, 27 but due to the key di erences in treatment planning
strategy and design discussed in Methods, a direct comparison to previous GTV/PTV dose
prediction results is not fair. Furthermore, the doses being predicted in this work are high, with
the majority over Rx. As a result, the raw and % of Rx errors will appear to be higher than
models focusing on OAR dose predictions.
Three axial slices of the planned dose, predicted dose, and the prediction error for a
representative pancreas SBRT plan are shown in Fig. 4. It is evident that the predicted dose
distribution is smoother than the planned dose because the prediction models did not consider
beam angles. As a result, the dose distribution heterogeneity and hot spots are not easily
predicted. Nevertheless, the prescription isodose lines are very similar between the planned
and predicted doses, suggesting that the model can accurately predict dose values near Rx as
well as clinical DVH metrics. Similar e ects were observed generally throughout the model
predictions. Note that the example in Fig. 4 was chosen as representative of typical predictions
but not necessarily matched with all average metrics tracked.
PDF
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Fig. 4
Open in gure viewer

PowerPoint

Three axial slices (inferior, center, and superior of GTV) of planned dose, model predicted dose,
and ΔDose of a representative patient plan (SBRT: Rx = 50 Gy, OARCRIT constraint = 36 Gy). All
OARs (stomach, duodenum, small bowel, large bowel, and spinal cord) are shown in white. The
prescription isodose lines are shown in blue for the planned and predicted dose views. Dose
prediction errors = 0.7 ± 3.9 Gy, absolute errors = 3.3 + 2.3 Gy. The plan metrics
(planned/predicted) are V95 = 90.4%/88.5%, V100 = 86.8%/85.1%, D95 = 42.6 Gy/41.4 Gy,
Dmean = 57.2 Gy/56.6 Gy.

The results of some predicted plan metrics vs their true plan values are shown in Fig. 5. Overall,
V95, V100, and D95 are well‐predicted, with R2 values of 0.97, 0.95, and 0.95, respectively, and
linear t slopes all near unity. The 25 inferior plans were well‐identi ed by their divergence
from the 95% PI for the V95 and V100 plan metrics. Figure 6(a) shows results for comparisons
between the real and predicted DVH metrics: error in Vx as a function of x where x is the
percentage of Rx (eg V95 = % of GTV volume receiving 95% of Rx). It is clear that Vx is predicted
well for x < 100% and large errors only occur for x > 100%. Figure 6(b) presents the overall dose
prediction error distributions in % Rx also as a function of x, con rming that per voxel dose
values are predicted well from x = 60%–100%.

PDF
Help

Fig. 5
Open in gure viewer

PowerPoint

Results for (a) V95, (b) V100, and (c) D95 predictions calculated from the model‘s 3D dose
predictions. The 45° dashed lines in each plot represent where the predicted and actual values
are equal. The linear t line and coe cient of determination (R2) are included. The outside
boundary lines represent the 95% PI. The 25 inferior plans identi ed during model re nement
are shown as *.

https://aapm.onlinelibrary.wiley.com/doi/full/10.1002/acm2.12884
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Fig. 6
Open in gure viewer

PowerPoint

Distributions of prediction error for (a) Vx: the percentage of the GTV volume receiving dose of at
least x percent of Rx (i.e. V20 through V160), and (b) dose in % Rx. The error distributions are
shown as boxplots with a horizontal red line for the median, blue box encompassing the 25%
and 75% interquartile ranges, and dotted line extending to the 95% range. The OARCRIT
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constraint (dotted) and Rx (dashed) levels are shown in the gures.

4 DISCUSSION
ANN models were designed in this study to predict 3D dose distributions based on the average
of prior plans used for model training. Our models allow a direct, 3D dose comparison between
the history of previously treated plans and upcoming plans for future patients without needing
to take the time and e ort to create an actual treatment plan. This is possible because our
models are based on inputs that require only target and OAR structure data, not planned beam
parameters. Because beam angles and related information were not included as input
https://aapm.onlinelibrary.wiley.com/doi/full/10.1002/acm2.12884
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variables, the models generally do not predict beam geometry‐dependent dose distribution
heterogeneity and hot spots for each individual patient’s plan. While overall raw dose errors
were not ideally low, the larger errors were generally associated with localized dose
heterogeneity and high dose regions above Rx (Fig. 6). From a clinical standpoint, such errors
are less relevant and do not a ect predictions for important DVH metrics such as V95, or
regions of the GTV receiving dose below Rx due to OAR sparing and constraint requirements.
Such overall plan metrics and the predicted balance between OAR sparing and GTV coverage
are the most important to guide adaptive decision‐making.
Due to the time constraints associated with the online adaptive process, adapted plans are not
a orded the same level of optimization and scrutiny as high‐quality o ine plans. The 3D dose
prediction models establish benchmarking that can enable a rapid evaluation of online
adaptive plans in terms of both plan quality and the overall dose distribution. Examples that
showcase this idea are evident in Fig. 5. The 25 plans deemed inferior during model re nement
are distinct from the general model predictions, with predicted values outside the 95% PI of at
least one plan quality metric. Future treatment plans that are inferior to the history of
previously treated plans could likely be identi ed similarly by testing with the model.
Several of the 25 plans identi ed as inferior were retrospectively replanned to assess for
potential improvement. Conditions that would be present during real‐time adaptation were
simulated for the replanning: no OAR constraints could be exceeded, optimization parameters
could be manually tweaked and adjusted, and time constraints for the reoptimization process
were kept in mind (~5 min maximum time allowed). Table 6 shows the results of the replanning
analysis. While the degree of improvement varied across the plans tested, all plans that were
reoptimized are closer to the quality claimed as possible by the ANN prediction model.
Generally, from 40–100% of the di erence between the predicted plan metrics and the original
values were recovered after replanning. These results help to further showcase the clinical
relevance and utility of the dose prediction models.
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Table 6. Results of the replanning by manual reoptimization for several plans from the groupHelpof
25 identi ed as inferior by the ANN prediction models.
Metric
V95 (%)

V100 (%)

Type

Plan 1

Plan 2

Plan 3

Plan 4

Clinical

52.6

82.3

72.6

80.4

RePlan

63.3

87.9

76.3

83.1

ANN

61.9

91.5

81.0

86.0

Clinical

45.6

70.9

65.0

70.7

https://aapm.onlinelibrary.wiley.com/doi/full/10.1002/acm2.12884
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Type

Plan 1

Plan 2

Plan 3

Plan 4

RePlan

60.0

84.5

70.4

75.6

ANN

60.7

89.0

79.3

82.4

Clinical

23.0

36.6

29.3

35.6

RePlan

22.7

38.9

35.2

37.3

ANN

23.5

42.3

38.0

39.1

Despite the potential applications of the models developed in this work, there are limitations
that must be addressed. First, the models were developed using only patient and plan data
from a single institution. Additionally, the inability of the models to account for hotspots or
other dramatic dose distribution changes prevents clinical applications that relate directly to
hotspots.43, 44 Dose prediction models would need to include more detailed plan information
related to beam angles and/or uence26, 27 in order to more accurately predict such metrics.
In future applications, the predicted 3D dose distributions could serve as an alternative input to
the treatment plan development process.26, 30 This is a particularly desirable strategy for
online adaptive plans, much in the same vein as it is being pursued for automated treatment
planning. An estimated 3D dose prediction tailored to the speci c anatomy of the day could
provide a much improved starting point for subsequent adapted plan development and
optimization each fraction. The fact that our ANN models can provide a 3D dose prediction
using contour information alone (a fully developed treatment plan is not needed) helps to
bolster their potential use as novel inputs for alternative treatment planning strategies.
Additional future work that could extend this study relates mostly to improving the 3D dosePDF
Help
prediction models. ANN model development and performance are based mainly on the ability
to identify key input data that strongly relates to making accurate output predictions. Most
likely, the best 3D dose prediction models would be based on convolutional neural networks
(CNNs),29-31 which have shown improved dose prediction performance relative to what was
achieved in this study. However, CNN models are well known to require vast amounts of
training data to learn the necessary relationships to make accurate and robust predictions.2931 As the number of patients treated with online adaptive MRgRT continues to increase, future
work may be possible related to CNN based prediction models with improved capabilities.

5 CONCLUSION
https://aapm.onlinelibrary.wiley.com/doi/full/10.1002/acm2.12884
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We developed ANN models to predict 3D dose distributions and overall plan quality metrics for
abdomen cancers in adaptive MRgRT. The prediction models will be useful to improve adaptive
planning strategies and work ows through more informed plan optimization and evaluation in
real time.
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